Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
Tandem drives Project Excellence across Life Science value chain
Tandem Project Management Ltd. delivers full project lifecycle solutions for global life science companies, combining technical excellence, regulatory expertise, and partnership-driven delivery across Ireland, the Netherlands, and the USA.
SGS Strengthens Technical Excellence across Ireland’s Key Industries
SGS Ireland strengthens quality, safety and compliance across key industries, combining local expertise with global technical excellence to help businesses operate with confidence and meet complex regulatory standards.
Precision Innovation
The life sciences and pharmaceutical sector continues to advance through technical expertise, operational excellence, and strategic innovation. Companies are increasingly focusing on precision, efficiency, and quality across research, manufacturing, and supply chain operations. SGS strengthens technical excellence across Ireland’s key industries underscores the importance of robust technical standards and compliance in supporting high-quality outputs and sustaining sector competitiveness. Tandem Project Management Ltd. delivers full project lifecycle solutions for global life science companies, combining technical excellence, regulatory expertise, and partnership-driven delivery across Ireland, the Netherlands, and the USA. Recognition of supply chain and service excellence continues to set benchmarks. Camida named Pharma Supplier of the Year reflects how dependable, innovative partners underpin the success of complex pharmaceutical operations. These developments illustrate a sector where precision, leadership, and strategic execution converge to drive meaningful progress in life sciences and pharmaceuticals. Read the full stories and stay informed on the innovations shaping the future of pharma and life sciences.
Camida Named Pharma Supplier of the Year at the Pharma Industry Awards 2024
Camida has been honoured with the Pharma Supplier of the Year award at the Pharma Industry Awards 2024, recognising its pivotal role in supporting the global life sciences, industrial, and ingredient sectors through its specialised sourcing and supply capabilities.
CZI and NVIDIA expand collaboration to accelerate AI-driven virtual cell model development
Chan Zuckerberg Initiative (CZI) and NVIDIA expand collaboration to accelerate virtual cell model development, scaling biological data processing to petabytes, enhancing AI-powered tools, models, and datasets via CZI’s open Virtual Cells Platform.
Belfast-based ARC Regulatory expands into Asia to tap booming life sciences market
ARC Regulator, Belfast-based precision medicine consultancy, expands into Asia to tap £260B life sciences market amid Western uncertainty, leveraging AI, regulatory expertise, and partnerships, following £3M Belfast lab and Derry hub investments.
Irish Scientists Showcase Cutting-Edge Cancer Nanomedicine and Targeted Therapies at Breakthrough Cancer Exhibition
Prof. Silvia Giordani and Dr. Neil Conlon showcased nanomedicine and targeted cancer therapies at the Breakthrough Cancer Exhibition, highlighting Irish-led innovations in drug delivery, smart medicines, and patient-focused cancer research.
SGS Expands Global Knowledge Access with Expert-Led Webinars on Regulatory and Analytical Trends
SGS continues to empower professionals worldwide through its series of expert-led webinars, offering in-depth insights into evolving regulatory expectations, analytical testing challenges, and global industry best practices.
Evolving Frontiers
The pharmaceutical and life sciences industry is entering a transformative phase, characterised by strategic realignment and long-term investment in innovation. As global demand grows for advanced therapies and sustainable production, major players are reconfiguring operations to enhance efficiency and scientific output. SGS continues to empower professionals worldwide through its series of expert-led webinars, offering in-depth insights into evolving regulatory expectations, analytical testing challenges, and global industry best practices. The US Food and Drug Administration (FDA) has announced new measures to accelerate the approval of biosimilar medicines, generic versions of complex biologics engineered from living cells, marking a major shift in the pharmaceutical landscape. Meanwhile, Kuehne+Nagel named title sponsor for Pharma Industry Awards 2025 highlights how collaboration between healthcare logistics and life sciences continues to strengthen sector-wide innovation and recognition. These developments illustrate an industry balancing progress with precision, advancing innovation while ensuring global access and operational excellence. Stay connected to the ideas shaping the future of pharma, explore the full stories in this edition of our newsletter.
Kuehne+Nagel announced as Title Sponsor for Pharma Industry Awards 2025
The Pharma Industry Awards 2025 proudly welcomes Kuehne+Nagel Ireland as this year’s Title Sponsor, underscoring the company’s long-standing commitment to advancing excellence and innovation within the pharmaceutical and life sciences sectors.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!


Sort by


.png)

